Clinical Chemistry Analyzers Market worth $11,728.01 Million by 2019

The “Clinical Chemistry Analyzer Market by Product (Systems & Reagents), Test Type (Basic Metabolic, Electrolyte, Liver, Lipid, Renal, Thyroid Function, Specialty Chemicals) & by End User (Hospitals, Laboratories, Academic Research) - Global Forecast to 2019” report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global clinical chemistry analyzers market along with the estimates and forecasts of the revenue and market share analysis.

http://www.marketsandmarkets.com/Market-Reports/clinical-chemistry-analyzer-market-144027310.html
Early buyers will receive 10% customization on reports

The clinical chemistry analyzers market is segmented on the basis of products as analyzers, reagents and other products. Analyzers segment is further divided on the basis of sizes into four segments: Small Sized (400-800 Test/H), Medium Sized (800-1,200 Tests/H), Large Sized (1,200-2,000 Tests/H), Very large Sized (2,000 Tests/H). The analyzer product segment had the largest share of the clinical chemistry analyzers market in 2014, whereas the reagents product segment is expected to grow at the highest CAGR between 2014 and 2019. Reagents segment is further categorized into calibrators, controls, standards and other reagents. The reagents product segment is expected to grow at the highest CAGR between 2014 and 2019.

Download FREE sample PDF Brochure@ http://www.marketsandmarkets.com/pdfdownload.asp?id=144027310

The application segments included in this report are tests such as, basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile/kidney function panel, thyroid function panel, specialty chemical tests. The basic metabolic panel tests segment had the largest share of the clinical chemistry analyzers market in 2014, whereas the lipid profile test segment is expected to grow at the highest CAGR between 2014 and 2019.

The geographic segments included in this report are Americas, Europe, BRIC, Japan and Rest of the World (RoW).

Rise in number of lifestyle diseases, automation of laboratories will aid the growth of this market. The market is expected to be driven by increasing awareness for preventative care, increase in aging population, increase in reagent rental agreements and laboratory automation.

The major players in the clinical chemistry analyzers market include Roche Diagnostics (Switzerland), Danaher Corporation (U.S.), Abbott Diagnostics(U.S.), Siemens AG (Germany), Ortho-Clinical Diagnostics(U.S.), Thermo Fisher Scientific(U.S.), Randox Laboratories Ltd.(U.K.), ElitechGroup (France), Mindray (China),and Horiba(Japan).